目次

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Application
Exhibit 06: Executive Summary - Chart on Market Segmentation by Drug Class
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ billion)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ billion)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size
4.1 Global anti-inflammatory therapeutics market 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on Global anti-inflammatory therapeutics market 2017 - 2021 ($ billion)
4.2 Application Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - Application Segment 2017 - 2021 ($ billion)
4.3 Drug class Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - Drug class Segment 2017 - 2021 ($ billion)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ billion)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ billion)

5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Application
6.1 Market segments
Exhibit 30: Chart on Application - Market share 2022-2027 (%)
Exhibit 31: Data Table on Application - Market share 2022-2027 (%)
6.2 Comparison by Application
Exhibit 32: Chart on Comparison by Application
Exhibit 33: Data Table on Comparison by Application
6.3 RA - Market size and forecast 2022-2027
Exhibit 34: Chart on RA - Market size and forecast 2022-2027 ($ billion)
Exhibit 35: Data Table on RA - Market size and forecast 2022-2027 ($ billion)
Exhibit 36: Chart on RA - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on RA - Year-over-year growth 2022-2027 (%)
6.4 Psoriasis - Market size and forecast 2022-2027
Exhibit 38: Chart on Psoriasis - Market size and forecast 2022-2027 ($ billion)
Exhibit 39: Data Table on Psoriasis - Market size and forecast 2022-2027 ($ billion)
Exhibit 40: Chart on Psoriasis - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Psoriasis - Year-over-year growth 2022-2027 (%)
6.5 MS - Market size and forecast 2022-2027
Exhibit 42: Chart on MS - Market size and forecast 2022-2027 ($ billion)
Exhibit 43: Data Table on MS - Market size and forecast 2022-2027 ($ billion)
Exhibit 44: Chart on MS - Year-over-year growth 2022-2027 (%)
Exhibit 45: Data Table on MS - Year-over-year growth 2022-2027 (%)
6.6 Market opportunity by Application
Exhibit 46: Market opportunity by Application ($ billion)

7 Market Segmentation by Drug Class
7.1 Market segments
Exhibit 47: Chart on Drug Class - Market share 2022-2027 (%)
Exhibit 48: Data Table on Drug Class - Market share 2022-2027 (%)
7.2 Comparison by Drug Class
Exhibit 49: Chart on Comparison by Drug Class
Exhibit 50: Data Table on Comparison by Drug Class
7.3 Anti-inflammatory biologicals - Market size and forecast 2022-2027
Exhibit 51: Chart on Anti-inflammatory biologicals - Market size and forecast 2022-2027 ($ billion)
Exhibit 52: Data Table on Anti-inflammatory biologicals - Market size and forecast 2022-2027 ($ billion)
Exhibit 53: Chart on Anti-inflammatory biologicals - Year-over-year growth 2022-2027 (%)
Exhibit 54: Data Table on Anti-inflammatory biologicals - Year-over-year growth 2022-2027 (%)
7.4 Corticosteroids - Market size and forecast 2022-2027
Exhibit 55: Chart on Corticosteroids - Market size and forecast 2022-2027 ($ billion)
Exhibit 56: Data Table on Corticosteroids - Market size and forecast 2022-2027 ($ billion)
Exhibit 57: Chart on Corticosteroids - Year-over-year growth 2022-2027 (%)
Exhibit 58: Data Table on Corticosteroids - Year-over-year growth 2022-2027 (%)
7.5 NSAIDs - Market size and forecast 2022-2027
Exhibit 59: Chart on NSAIDs - Market size and forecast 2022-2027 ($ billion)
Exhibit 60: Data Table on NSAIDs - Market size and forecast 2022-2027 ($ billion)
Exhibit 61: Chart on NSAIDs - Year-over-year growth 2022-2027 (%)
Exhibit 62: Data Table on NSAIDs - Year-over-year growth 2022-2027 (%)
7.6 Market opportunity by Drug Class
Exhibit 63: Market opportunity by Drug Class ($ billion)

8 Customer Landscape
8.1 Customer landscape overview
Exhibit 64: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 65: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibit 66: Data Table on Market share By Geographical Landscape 2022-2027 (%)
9.2 Geographic comparison
Exhibit 67: Chart on Geographic comparison
Exhibit 68: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
Exhibit 69: Chart on North America - Market size and forecast 2022-2027 ($ billion)
Exhibit 70: Data Table on North America - Market size and forecast 2022-2027 ($ billion)
Exhibit 71: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 72: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 Europe - Market size and forecast 2022-2027
Exhibit 73: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibit 74: Data Table on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibit 75: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 76: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.5 Asia - Market size and forecast 2022-2027
Exhibit 77: Chart on Asia - Market size and forecast 2022-2027 ($ billion)
Exhibit 78: Data Table on Asia - Market size and forecast 2022-2027 ($ billion)
Exhibit 79: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 80: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 81: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
Exhibit 82: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
Exhibit 83: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 84: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 85: Chart on US - Market size and forecast 2022-2027 ($ billion)
Exhibit 86: Data Table on US - Market size and forecast 2022-2027 ($ billion)
Exhibit 87: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 88: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 Germany - Market size and forecast 2022-2027
Exhibit 89: Chart on Germany - Market size and forecast 2022-2027 ($ billion)
Exhibit 90: Data Table on Germany - Market size and forecast 2022-2027 ($ billion)
Exhibit 91: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 92: Data Table on Germany - Year-over-year growth 2022-2027 (%)
9.9 UK - Market size and forecast 2022-2027
Exhibit 93: Chart on UK - Market size and forecast 2022-2027 ($ billion)
Exhibit 94: Data Table on UK - Market size and forecast 2022-2027 ($ billion)
Exhibit 95: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibit 96: Data Table on UK - Year-over-year growth 2022-2027 (%)
9.10 Canada - Market size and forecast 2022-2027
Exhibit 97: Chart on Canada - Market size and forecast 2022-2027 ($ billion)
Exhibit 98: Data Table on Canada - Market size and forecast 2022-2027 ($ billion)
Exhibit 99: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibit 100: Data Table on Canada - Year-over-year growth 2022-2027 (%)
9.11 China - Market size and forecast 2022-2027
Exhibit 101: Chart on China - Market size and forecast 2022-2027 ($ billion)
Exhibit 102: Data Table on China - Market size and forecast 2022-2027 ($ billion)
Exhibit 103: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 104: Data Table on China - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 105: Market opportunity By Geographical Landscape ($ billion)

10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 106: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends

11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 107: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 108: Overview on factors of disruption
11.4 Industry risks
Exhibit 109: Impact of key risks on business

12 Vendor Analysis
12.1 Vendors covered
Exhibit 110: Vendors covered
12.2 Market positioning of vendors
Exhibit 111: Matrix on vendor position and classification
12.3 AbbVie Inc.
Exhibit 112: AbbVie Inc. - Overview
Exhibit 113: AbbVie Inc. - Product / Service
Exhibit 114: AbbVie Inc. - Key news
Exhibit 115: AbbVie Inc. - Key offerings
12.4 Alvogen Iceland ehf
Exhibit 116: Alvogen Iceland ehf - Overview
Exhibit 117: Alvogen Iceland ehf - Product / Service
Exhibit 118: Alvogen Iceland ehf - Key offerings
12.5 Amgen Inc.
Exhibit 119: Amgen Inc. - Overview
Exhibit 120: Amgen Inc. - Product / Service
Exhibit 121: Amgen Inc. - Key offerings
12.6 Amneal Pharmaceuticals Inc.
Exhibit 122: Amneal Pharmaceuticals Inc. - Overview
Exhibit 123: Amneal Pharmaceuticals Inc. - Business segments
Exhibit 124: Amneal Pharmaceuticals Inc. - Key news
Exhibit 125: Amneal Pharmaceuticals Inc. - Key offerings
Exhibit 126: Amneal Pharmaceuticals Inc. - Segment focus
12.7 Bayer AG
Exhibit 127: Bayer AG - Overview
Exhibit 128: Bayer AG - Business segments
Exhibit 129: Bayer AG - Key news
Exhibit 130: Bayer AG - Key offerings
Exhibit 131: Bayer AG - Segment focus
12.8 Bristol Myers Squibb Co.
Exhibit 132: Bristol Myers Squibb Co. - Overview
Exhibit 133: Bristol Myers Squibb Co. - Product / Service
Exhibit 134: Bristol Myers Squibb Co. - Key news
Exhibit 135: Bristol Myers Squibb Co. - Key offerings
12.9 Eli Lilly and Co.
Exhibit 136: Eli Lilly and Co. - Overview
Exhibit 137: Eli Lilly and Co. - Product / Service
Exhibit 138: Eli Lilly and Co. - Key offerings
12.10 F. Hoffmann-La Roche Ltd
Exhibit 139: F. Hoffmann-La Roche Ltd - Overview
Exhibit 140: F. Hoffmann-La Roche Ltd - Product / Service
Exhibit 141: F. Hoffmann-La Roche Ltd - Key offerings
12.11 Ferring BV
Exhibit 142: Ferring BV - Overview
Exhibit 143: Ferring BV - Product / Service
Exhibit 144: Ferring BV - Key offerings
12.12 GlaxoSmithKline Plc
Exhibit 145: GlaxoSmithKline Plc - Overview
Exhibit 146: GlaxoSmithKline Plc - Business segments
Exhibit 147: GlaxoSmithKline Plc - Key offerings
Exhibit 148: GlaxoSmithKline Plc - Segment focus
12.13 Johnson and Johnson
Exhibit 149: Johnson and Johnson - Overview
Exhibit 150: Johnson and Johnson - Business segments
Exhibit 151: Johnson and Johnson - Key news
Exhibit 152: Johnson and Johnson - Key offerings
Exhibit 153: Johnson and Johnson - Segment focus
12.14 Mylan N.V
Exhibit 154: Mylan N.V - Overview
Exhibit 155: Mylan N.V - Product / Service
Exhibit 156: Mylan N.V - Key offerings
12.15 Novartis AG
Exhibit 157: Novartis AG - Overview
Exhibit 158: Novartis AG - Business segments
Exhibit 159: Novartis AG - Key offerings
Exhibit 160: Novartis AG - Segment focus
12.16 Pfizer Inc.
Exhibit 161: Pfizer Inc. - Overview
Exhibit 162: Pfizer Inc. - Product / Service
Exhibit 163: Pfizer Inc. - Key news
Exhibit 164: Pfizer Inc. - Key offerings
12.17 Teva Pharmaceutical Industries Ltd.
Exhibit 165: Teva Pharmaceutical Industries Ltd. - Overview
Exhibit 166: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibit 167: Teva Pharmaceutical Industries Ltd. - Key news
Exhibit 168: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibit 169: Teva Pharmaceutical Industries Ltd. - Segment focus

13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 170: Inclusions checklist
Exhibit 171: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 172: Currency conversion rates for US$
13.4 Research methodology
Exhibit 173: Research methodology
Exhibit 174: Validation techniques employed for market sizing
Exhibit 175: Information sources
13.5 List of abbreviations
Exhibit 176: List of abbreviations

Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Application
Exhibits6: Executive Summary - Chart on Market Segmentation by Drug Class
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ billion)
Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ billion)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size - Data Table on Global anti-inflammatory therapeutics market 2017 - 2021 ($ billion)
Exhibits19: Historic Market Size - Application Segment 2017 - 2021 ($ billion)
Exhibits20: Historic Market Size - Drug class Segment 2017 - 2021 ($ billion)
Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ billion)
Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ billion)
Exhibits23: Five forces analysis - Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition - Five forces 2022 and 2027
Exhibits30: Chart on Application - Market share 2022-2027 (%)
Exhibits31: Data Table on Application - Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Application
Exhibits33: Data Table on Comparison by Application
Exhibits34: Chart on RA - Market size and forecast 2022-2027 ($ billion)
Exhibits35: Data Table on RA - Market size and forecast 2022-2027 ($ billion)
Exhibits36: Chart on RA - Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on RA - Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Psoriasis - Market size and forecast 2022-2027 ($ billion)
Exhibits39: Data Table on Psoriasis - Market size and forecast 2022-2027 ($ billion)
Exhibits40: Chart on Psoriasis - Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Psoriasis - Year-over-year growth 2022-2027 (%)
Exhibits42: Chart on MS - Market size and forecast 2022-2027 ($ billion)
Exhibits43: Data Table on MS - Market size and forecast 2022-2027 ($ billion)
Exhibits44: Chart on MS - Year-over-year growth 2022-2027 (%)
Exhibits45: Data Table on MS - Year-over-year growth 2022-2027 (%)
Exhibits46: Market opportunity by Application ($ billion)
Exhibits47: Chart on Drug Class - Market share 2022-2027 (%)
Exhibits48: Data Table on Drug Class - Market share 2022-2027 (%)
Exhibits49: Chart on Comparison by Drug Class
Exhibits50: Data Table on Comparison by Drug Class
Exhibits51: Chart on Anti-inflammatory biologicals - Market size and forecast 2022-2027 ($ billion)
Exhibits52: Data Table on Anti-inflammatory biologicals - Market size and forecast 2022-2027 ($ billion)
Exhibits53: Chart on Anti-inflammatory biologicals - Year-over-year growth 2022-2027 (%)
Exhibits54: Data Table on Anti-inflammatory biologicals - Year-over-year growth 2022-2027 (%)
Exhibits55: Chart on Corticosteroids - Market size and forecast 2022-2027 ($ billion)
Exhibits56: Data Table on Corticosteroids - Market size and forecast 2022-2027 ($ billion)
Exhibits57: Chart on Corticosteroids - Year-over-year growth 2022-2027 (%)
Exhibits58: Data Table on Corticosteroids - Year-over-year growth 2022-2027 (%)
Exhibits59: Chart on NSAIDs - Market size and forecast 2022-2027 ($ billion)
Exhibits60: Data Table on NSAIDs - Market size and forecast 2022-2027 ($ billion)
Exhibits61: Chart on NSAIDs - Year-over-year growth 2022-2027 (%)
Exhibits62: Data Table on NSAIDs - Year-over-year growth 2022-2027 (%)
Exhibits63: Market opportunity by Drug Class ($ billion)
Exhibits64: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits65: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits66: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits67: Chart on Geographic comparison
Exhibits68: Data Table on Geographic comparison
Exhibits69: Chart on North America - Market size and forecast 2022-2027 ($ billion)
Exhibits70: Data Table on North America - Market size and forecast 2022-2027 ($ billion)
Exhibits71: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits72: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits73: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibits74: Data Table on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibits75: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits76: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits77: Chart on Asia - Market size and forecast 2022-2027 ($ billion)
Exhibits78: Data Table on Asia - Market size and forecast 2022-2027 ($ billion)
Exhibits79: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits80: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits81: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
Exhibits82: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
Exhibits83: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits84: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits85: Chart on US - Market size and forecast 2022-2027 ($ billion)
Exhibits86: Data Table on US - Market size and forecast 2022-2027 ($ billion)
Exhibits87: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits88: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits89: Chart on Germany - Market size and forecast 2022-2027 ($ billion)
Exhibits90: Data Table on Germany - Market size and forecast 2022-2027 ($ billion)
Exhibits91: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits92: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits93: Chart on UK - Market size and forecast 2022-2027 ($ billion)
Exhibits94: Data Table on UK - Market size and forecast 2022-2027 ($ billion)
Exhibits95: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits96: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits97: Chart on Canada - Market size and forecast 2022-2027 ($ billion)
Exhibits98: Data Table on Canada - Market size and forecast 2022-2027 ($ billion)
Exhibits99: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibits100: Data Table on Canada - Year-over-year growth 2022-2027 (%)
Exhibits101: Chart on China - Market size and forecast 2022-2027 ($ billion)
Exhibits102: Data Table on China - Market size and forecast 2022-2027 ($ billion)
Exhibits103: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits104: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits105: Market opportunity By Geographical Landscape ($ billion)
Exhibits106: Impact of drivers and challenges in 2022 and 2027
Exhibits107: Overview on Criticality of inputs and Factors of differentiation
Exhibits108: Overview on factors of disruption
Exhibits109: Impact of key risks on business
Exhibits110: Vendors covered
Exhibits111: Matrix on vendor position and classification
Exhibits112: AbbVie Inc. - Overview
Exhibits113: AbbVie Inc. - Product / Service
Exhibits114: AbbVie Inc. - Key news
Exhibits115: AbbVie Inc. - Key offerings
Exhibits116: Alvogen Iceland ehf - Overview
Exhibits117: Alvogen Iceland ehf - Product / Service
Exhibits118: Alvogen Iceland ehf - Key offerings
Exhibits119: Amgen Inc. - Overview
Exhibits120: Amgen Inc. - Product / Service
Exhibits121: Amgen Inc. - Key offerings
Exhibits122: Amneal Pharmaceuticals Inc. - Overview
Exhibits123: Amneal Pharmaceuticals Inc. - Business segments
Exhibits124: Amneal Pharmaceuticals Inc. - Key news
Exhibits125: Amneal Pharmaceuticals Inc. - Key offerings
Exhibits126: Amneal Pharmaceuticals Inc. - Segment focus
Exhibits127: Bayer AG - Overview
Exhibits128: Bayer AG - Business segments
Exhibits129: Bayer AG - Key news
Exhibits130: Bayer AG - Key offerings
Exhibits131: Bayer AG - Segment focus
Exhibits132: Bristol Myers Squibb Co. - Overview
Exhibits133: Bristol Myers Squibb Co. - Product / Service
Exhibits134: Bristol Myers Squibb Co. - Key news
Exhibits135: Bristol Myers Squibb Co. - Key offerings
Exhibits136: Eli Lilly and Co. - Overview
Exhibits137: Eli Lilly and Co. - Product / Service
Exhibits138: Eli Lilly and Co. - Key offerings
Exhibits139: F. Hoffmann-La Roche Ltd - Overview
Exhibits140: F. Hoffmann-La Roche Ltd - Product / Service
Exhibits141: F. Hoffmann-La Roche Ltd - Key offerings
Exhibits142: Ferring BV - Overview
Exhibits143: Ferring BV - Product / Service
Exhibits144: Ferring BV - Key offerings
Exhibits145: GlaxoSmithKline Plc - Overview
Exhibits146: GlaxoSmithKline Plc - Business segments
Exhibits147: GlaxoSmithKline Plc - Key offerings
Exhibits148: GlaxoSmithKline Plc - Segment focus
Exhibits149: Johnson and Johnson - Overview
Exhibits150: Johnson and Johnson - Business segments
Exhibits151: Johnson and Johnson - Key news
Exhibits152: Johnson and Johnson - Key offerings
Exhibits153: Johnson and Johnson - Segment focus
Exhibits154: Mylan N.V - Overview
Exhibits155: Mylan N.V - Product / Service
Exhibits156: Mylan N.V - Key offerings
Exhibits157: Novartis AG - Overview
Exhibits158: Novartis AG - Business segments
Exhibits159: Novartis AG - Key offerings
Exhibits160: Novartis AG - Segment focus
Exhibits161: Pfizer Inc. - Overview
Exhibits162: Pfizer Inc. - Product / Service
Exhibits163: Pfizer Inc. - Key news
Exhibits164: Pfizer Inc. - Key offerings
Exhibits165: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits166: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits167: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits168: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits169: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits170: Inclusions checklist
Exhibits171: Exclusions checklist
Exhibits172: Currency conversion rates for US$
Exhibits173: Research methodology
Exhibits174: Validation techniques employed for market sizing
Exhibits175: Information sources
Exhibits176: List of abbreviations